Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).

No abstract is available for this paper.

• Publication year

  1970

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1970-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1210/JCEM-31-4-382PMID 5468701
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dissociation of serum LATS content and thyroid suppressibility during treatment of hyperthyroidism.

  1970cited by this paper
• Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease.

  1969cited by this paper
• Classification of the eye changes of Grave's disease.

  1969cited by this paper
• The value of IgG separation for the detection of LATS in human serum.

  1969cited by this paper
• A modification of the McKenzie bioassay for long-acting thyroid stimulator (LATS).

  1969cited by this paper
• Humoral factors in the pathogenesis of Graves' disease.

  1968cited by this paper
• The long-acting thyroid stimulator of Graves' disease.

  1968cited by this paper
• Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.

  1967cited by this paper
• Statistical Method in Biological Assay

  1966cited by this paper
• Clinical evaluation of a new method for the determination of serum thyroxine.

  1966cited by this paper
• Relation between long-acting thyroid stimulator and thyroid function in thyrotoxicosis.

  1966cited by this paper
• Non-specific responses in the assay of thyrotrophin and long-acting thyroid stimulator.

  1966cited by this paper
• Recovery of the long-acting thyroid stimulator from serum of patients with thyrotoxicosis by concentration of immunoglobulin G.

  1966cited by this paper
• An improved bio-assay for TSH by modification of the method of McKenzie.

  1966cited by this paper
• Pathogenesis of the Hyperthyroidism of Graves's Disease*

  1965cited by this paper
• PRESENCE OF THE LONG-ACTING THYROID STIMULATOR IN SERUM IN MONGOLISM WITHOUT HYPERTHYROIDISM.

  1965cited by this paper
• ISOLATION AND IDENTIFICATION OF THE LONG-ACTING THYROID STIMULATOR AND ITS RELATION TO HYPERTHYROIDISM AND CIRCUMSCRIBED PRETIBIAL MYXEDEMA.

  1964cited by this paper
• The severe eye changes of Graves' disease.

  1961cited by this paper
• The bioassay of thyrotropin in serum.

  1958cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Thyroid autoantibodies.

  2001cites this paper
• Thyroid Autoantibodies in Graves’ Disease

  2000cites this paper
• The Thyrotropin (TSH)-Releasing Hormone Receptor: Interaction with TSH and Autoantibodies

  1998cites this paper
• The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies.

  1998cites this paper
• The spectrum and significance of autoantibodies reacting with the thyrotropin receptor.

  1987cites this paper
• Characteristics of antibodies to calmodulin in patients with Graves' disease.

  1987cites this paper
• Stimulation of thyroidal iodothyronine 5'-monodeiodinase by long-acting thyroid stimulator (LATS).

  1987cites this paper
• Thyroid stimulating immunoglobulins: measurement and clinical use.

  1985cites this paper
• Immune mechanisms in Graves' disease.

  1985cites this paper
• Pathogenesis of hyperthyroidism.

  1983cites this paper
• Thyroid-stimulating antibodies in Grave's disease and the effect of thyrotrophin-binding globulins on their determination.

  1982cites this paper
• Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.

  1981cites this paper
• Specific binding of thyroid-stimulating hormone by human serum globulins.

  1981cites this paper
• Graves' ophthalmopathy. A clinical and immunologic review.

  1981cites this paper
• TSH binding by globulins from patients with Graves' disease.

  1981cites this paper
• THYROTROPHIN BINDING INHIBITING IMMUNOGLOBULINS IN GRAVES' DISEASE BEFORE, DURING AND AFTER ANTITHYROID THERAPY, AND ITS RELATION TO LONG‐ACTING THYROID STIMULATOR

  1980cites this paper
• Binding of THS by normal and TSI-containing globulins.

  1980cites this paper
• [Neonatal hyperthyroidism. Description of a case and brief review of the literature].

  1979cites this paper
• Relationships among immunoglobulin markers in Graves' disease.

  1979cites this paper
• A simplified method for diagnosis of gestational age in the newborn infant.

  1978cites this paper
• Autoimmune Thyroid Diseases—Graves' and Hashimoto's

  1978cites this paper
• Neonatal thyrotoxicosis: alterations in serum concentrations of LATS-protector, T4, T3, reverse T3, and 3,3'T2.

  1978cites this paper
• Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.

  1977cites this paper
• Endocrine exophthalmos: an immunologic aberration.

  1977cites this paper
• Some peripheral effects of thyroid stimulating substances

  1977cites this paper
• Human thyroid adenyl cyclase-stimulating activity in immunoglobulin G of patients with Graves' disease.

  1976cites this paper
• [An antibody called LATS].

  1975cites this paper
• Editorial: hyperthyroidism and Grave's disease.

  1975cites this paper
• Aetiology of hyperthyroidism. II.

  1974cites this paper
• Pretibial myxedema and nonthyrotoxic thyroid disease.

  1973cites this paper
• The effects on rabbits of immunization with bovine thyroid-stimulating hormone and its subunits.

  1973cites this paper
• The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts.

  1973cites this paper
• Bovine Thyroid-Stimulating Hormone and its Subunits

  1973cites this paper
• New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.

  1973cites this paper
• Isoelectric focusing of long-acting thyroid stimulator immunoglobulin G.

  1973cites this paper
• Abnormalities of hypothalamo-hypophyseal-thyroid axis in patients with Graves' ophthalmopathy.

  1973cites this paper
• Circulating inhibitor of LATS: a bioassay artefact.

  1973cites this paper
• Alterations in circulating estradiol-17 in male patients with Graves's disease.

  1972cites this paper
• The long-acting thyroid stimulator and the result of I 131 treatment for thyrotoxicosis.

  1972cites this paper
• Alterations in circulating estradiol-17-beta in male patients with Graves's disease.

  1972cites this paper
• Some recent developments in the physiology of the thyroid gland.

  1972cites this paper
• Does LATS cause hyperthyroidism in Graves' disease? (A review biased toward the affirmative).

  1972cites this paper
• [Concentration of plasma in hyperthyroid patients for the detection of G immunoglobulins with LATS activity].

  1972cites this paper
• Graves' disease--1972.

  1972cites this paper
• Clinical significance of LATS and TSH in the blood.

  1972cites this paper
• Positive correlation of the long-acting thyroid stimulator (LATS) with the percentage of endogenously labelled 131 I triiodothyronine in the plasma of hyperthyroid patients.

  1971cites this paper
• Thyroid suppression and the long-acting thyroid stimulator following radioactive iodine therapy for thyrotoxicosis.

  1971cites this paper
• The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy.

  1971cites this paper
• LATS inhibition by a soluble lipoprotein from human thyroid gland.

  1971cites this paper
• Treatment of thyrotoxicosis.

  1970cites this paper
• Thyroid gland in Graves' disease: victim or culprit?

  1970cites this paper
• Graves' disease with delayed hyperthyroidism. Onset after several years of euthyroid ophthalmopathy, dermopathy, and high serum LATS.

  1970cites this paper